Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-05

Clinical Trial Update: Randomized, Triple-Blind, Placebo-Controlled Trial of Topical Dapsone Gel in Patients With Acne Vulgaris [Phase 4]

View source ↗

Summary

Phase 4 randomized, triple-blind, placebo-controlled trial evaluating topical dapsone gel for acne vulgaris; enrollment is by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topical Dapsone Gel (dapsone)

Snippet

Sponsor: Oya Helin Dundar | Conditions: Acne Vulgaris | Phase 4 | Status: ENROLLING_BY_INVITATION